AKTX - Akari Therapeutics Plc
Previous close
1.005
0 0%
Share volume: 600
Last Updated: Fri 27 Dec 2024 06:42:27 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.00
0.00
0.00%
Summary score
25%
Profitability
25%
Dept financing
22%
Liquidity
28%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-28.85%
Return on assets
-47.32%
Return on sales
0%
Return on invested capital
62.71%
Total debt ratio
60.06%
Debt ratio change over timeo
1.27%
Current Ratio
2.12%
Quick Ratio
0%
Cash Position Ratio
1.49%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.04%
Return on assets
-66.28%
Return on sales
0%
Return on invested capital
63.03%
Total debt ratio
88.57%
Debt ratio change over timeo
0.77%
Current Ratio
1.15%
Quick Ratio
0%
Cash Position Ratio
0.9%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-249.69%
Return on assets
-41%
Return on sales
0%
Return on invested capital
75.2%
Total debt ratio
76.9%
Debt ratio change over time
0.78%
Current Ratio
1.3%
Quick Ratio
0%
Cash Position Ratio
1.15%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-278.52%
Return on assets
-290.93%
Return on sales
0%
Return on invested capital
327.65%
Total debt ratio
127.04%
Debt ratio change over time
1.27%
Current Ratio
12.49%
Quick Ratio
0%
Cash Position Ratio
11.39%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AKTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -28.85% | -3.05% | 11.55% | 6.27% |
| Return on assets | -47.32% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 62.71% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 38% | 70% | 63% |
| Total debt ratio | 60.06% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | 1.27% | 6.09% | 6.03% | 1.53% |
| Dept financing | 20% | 50% | 43% | 14% |
| Current Ratio | 1.15% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 0.9% | 1.48% | 0.76% | 1.49% |
| Liquididy | 40% | 33% | 60% | 69% |
| Short-term ratios | AKTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.04% | -25.62% | 17.94% | 7.14% |
| Return on assets | -66.28% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 63.03% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 41% | 72% | 65% |
| Total debt ratio | 88.57% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | 0.77% | -23.44% | 9.66% | 0.6% |
| Dept financing | 23% | 25% | 45% | 8% |
| Current Ratio | 1.15% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 0.9% | 1.48% | 0.76% | 1.49% |
| Liquididy | 23% | 57% | 42% | 75% |